Social Media Guidance Gives Drug Firms A Pass On User Content
This article was originally published in The Tan Sheet
Executive Summary
The draft guidance outlines substantial reporting requirements for websites that firms control and for content on third-party sites – as well as saying when FDA intends to use enforcement discretion.
You may also be interested in...
Mucinex, Zyrtec Online Strategies Score While Most OTC Brands Miss
RB's Mucinex brand ranks highest among OTC drug brands evaluated in digital research firm L2’s Digital IQ Index, which found the OTC sector ranked last in digital ad spend among the top 10 industries. OTC product brands tend to be unsophisticated online and do not adequately link products to points of purchase.
Mucinex, Zyrtec Online Strategies Score While Most OTC Brands Miss
RB's Mucinex brand ranks highest among OTC drug brands evaluated in digital research firm L2’s Digital IQ Index, which found the OTC sector ranked last in digital ad spend among the top 10 industries. OTC product brands tend to be unsophisticated online and do not adequately link products to points of purchase.
To Improve Adverse Event Tracking, FDA Could Google It
Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse-event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.